中遠海科(002401.SZ):公司目前處在“第二曲線孵化期”,成效初顯
格隆匯9月14日丨中遠海科(002401.SZ)在投資者關係活動上表示,公司目前處在“第二曲線孵化期”,成效初顯。一是圍繞賦能中遠海運集團和航運供應鏈相關行業做大做強公司數字航運與供應鏈業務,2024年上半年公司數字航運與供應鏈業務營業收入3.79億元,同比增長43.86%。二是推進數字城市和交通業務的數字化轉型升級,將傳統智能交通系統集成逐步擴展至數字城市與治理領域。後續公司將進一步結合數字經濟和行業發展新趨勢,進一步加大關鍵領域科研投入,提升市場核心競爭力,夯實第二曲線發展基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.